Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rizzoli

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Haematologica|May 1, 1997
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cellsC Carlo-Stella, E Regazzi, C Andrizzi, et al.
Haematologica|May 1, 1988
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycinG Visani, V Rizzoli, A Dinota, et al.
Leukemia|October 1, 1991
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT)N C Gorin, M Labopin, G Meloni, et al.
Leukemia|October 7, 2005
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patientsS Colla, F Morandi, M Lazzaretti, et al.
Bone Marrow Transplantation|December 1, 1989
Purging procedures for acute leukaemias in autologous BMTV Rizzoli, L Mangoni, A M Carella, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
Leukemia|November 1, 1992
Autologous bone marrow transplantation for acute myeloid and lymphoid leukemiaV Rizzoli, C Carlo-Stella, C Almici, et al.
Blut|March 1, 1990
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomasF Gherlinzoni, P Mazza, P L Zinzani, et al.
Blood|October 15, 1996
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genisteinC Carlo-Stella, G Dotti, L Mangoni, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Haematologica|May 1, 1997
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cellsC Carlo-Stella, E Regazzi, C Andrizzi, et al.
Haematologica|May 1, 1988
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycinG Visani, V Rizzoli, A Dinota, et al.
Leukemia|October 1, 1991
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT)N C Gorin, M Labopin, G Meloni, et al.
Leukemia|October 7, 2005
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patientsS Colla, F Morandi, M Lazzaretti, et al.
Bone Marrow Transplantation|December 1, 1989
Purging procedures for acute leukaemias in autologous BMTV Rizzoli, L Mangoni, A M Carella, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
Leukemia|November 1, 1992
Autologous bone marrow transplantation for acute myeloid and lymphoid leukemiaV Rizzoli, C Carlo-Stella, C Almici, et al.
Blut|March 1, 1990
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomasF Gherlinzoni, P Mazza, P L Zinzani, et al.
Blood|October 15, 1996
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genisteinC Carlo-Stella, G Dotti, L Mangoni, et al.
Pageof 18